Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges

Shihua H. Wang; Ashok K. Shetty; Kunlin Jin; Robert Chunhua Zhao

doi:10.3389/fcell.2020.627414

Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges

Shihua H. Wang, Ashok K. Shetty, Kunlin Jin, Robert Chunhua Zhao

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	627414
Journal	Frontiers in Cell and Developmental Biology
Volume	8
DOIs	https://doi.org/10.3389/fcell.2020.627414
State	Published - 5 Jan 2021

Keywords

COVID-19
exosome
extracellular vesicle
mesenchymal stem cell
therapy

Access to Document

10.3389/fcell.2020.627414

Cite this

@article{7eb59c74d0114ee9b85d942cd24b77bc,

title = "Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges",

keywords = "COVID-19, exosome, extracellular vesicle, mesenchymal stem cell, therapy",

author = "Wang, {Shihua H.} and Shetty, {Ashok K.} and Kunlin Jin and {Chunhua Zhao}, Robert",

note = "Funding Information: This work was funded by National Natural Science Foundation of China (Grant No. 81902848), the Fundamental Research Funds for the Central University (3332019062), CAMS Innovation Fund for Medical Sciences (2017-I2M-3-007), The National Key Research and Development Program of China (2016YFA0101000 and 2016YFA0101003), Beijing Key Laboratory of New Drug Development, and Clinical Trial of Stem Cell Therapy (BZ0381), National Institutes of Health (R01 NS106907 to AS).",

year = "2021",

month = jan,

day = "5",

doi = "10.3389/fcell.2020.627414",

language = "English",

volume = "8",

journal = "Frontiers in Cell and Developmental Biology",

issn = "2296-634X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy

T2 - Promise and Challenges

AU - Wang, Shihua H.

AU - Shetty, Ashok K.

AU - Jin, Kunlin

AU - Chunhua Zhao, Robert

N1 - Funding Information: This work was funded by National Natural Science Foundation of China (Grant No. 81902848), the Fundamental Research Funds for the Central University (3332019062), CAMS Innovation Fund for Medical Sciences (2017-I2M-3-007), The National Key Research and Development Program of China (2016YFA0101000 and 2016YFA0101003), Beijing Key Laboratory of New Drug Development, and Clinical Trial of Stem Cell Therapy (BZ0381), National Institutes of Health (R01 NS106907 to AS).

PY - 2021/1/5

Y1 - 2021/1/5

KW - COVID-19

KW - exosome

KW - extracellular vesicle

KW - mesenchymal stem cell

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85099652138&partnerID=8YFLogxK

U2 - 10.3389/fcell.2020.627414

DO - 10.3389/fcell.2020.627414

M3 - Article

AN - SCOPUS:85099652138

VL - 8

JO - Frontiers in Cell and Developmental Biology

JF - Frontiers in Cell and Developmental Biology

SN - 2296-634X

M1 - 627414

ER -

Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges

Keywords

Access to Document

Other files and links

Cite this